Clinical Trials Directory

Trials / Completed

CompletedNCT00249639

Contingency Management for Attendance - 2

Contingency Management for Attendance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
300 (actual)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effectiveness of a low-cost contingency management procedure as compared to standard treatment. Using a cross-over design, CM is implemented at different community-based clinics and compared with non-CM in the same facilities. Research staff collects information regarding patients' demographic characteristics, attendance, and outcomes at the clinics. During Phase A (non-CM), standard clinical practice is in place. During Phase B (CM), all patients have the chance to win prizes by coming to treatment. Each participating clinic is randomly assigned to receive either the A or B phase first; each phase is in effect for 16 weeks.

Conditions

Interventions

TypeNameDescription
BEHAVIORALContingency managementRewards valued $1-$100

Timeline

Start date
2004-01-01
Primary completion
2006-01-01
Completion
2006-01-01
First posted
2005-11-07
Last updated
2017-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00249639. Inclusion in this directory is not an endorsement.